TY - JOUR
T1 - Autoimmune inner ear disease
T2 - Diagnostic and therapeutic approaches in a multidisciplinary setting
AU - Matteson, Eric L.
AU - Fabry, David A.
AU - Strome, Scott E.
AU - Driscoll, Colin L.W.
AU - Beatty, Charles W.
AU - McDonald, Thomas J.
N1 - Funding Information:
*Department of Internal Medicine, Division of Rheumatology **Division of Audiology. Department of Otorhinolaryngology tDepartment of Otorhinolaryngology, Mayo Clinic and Mayo Graduate Schooi of Medicine Rochester, Minnesota Corresponding Author: Thomas J. McDonald, M.D., Professor and Chair, Department of Otorhinolaryngology, Mayo Clinic Rochester, MN 55905, Phone: 507-284-3976, Fax: 507-284-8855, E-mail: tjmcdonald@mayo.edu This work is in part supported by grants from the Mayo Clinic Foundation and Immunex Corporation to Dr. Matteson, and an unrestricted grant from Mr. and Mrs. Jesse Jones.
PY - 2003/4
Y1 - 2003/4
N2 - Autoimmune Inner Ear Disease (AIED) is a clinical syndrome of uncertain pathogenesis. It is associated with bilateral rapidly progressive hearing loss. The hearing loss may be associated with vestibular symptoms. Autoimmunity has been proposed as the pathogenesis of this sort of hearing loss, although the mechanism of the disease is poorly understood. It is well accepted that the endolymphatic sac is an immunocompetent organ and circulating autoantibodies against inner ear antigens have been reported, as have viral antigens in the endolymph, although the sensitivity, specificity, and roles of those antibodies in a disease process are poorly defined. We will describe the clinical aspects of the disease, the histopathology, the immunologic indicators, the types of presentation, both from the audiologic and vestibular point of view, clinical trials for treatment and the follow-up. One of our conclusions is that many of these patients respond favorably to the treatment Methotrexate.
AB - Autoimmune Inner Ear Disease (AIED) is a clinical syndrome of uncertain pathogenesis. It is associated with bilateral rapidly progressive hearing loss. The hearing loss may be associated with vestibular symptoms. Autoimmunity has been proposed as the pathogenesis of this sort of hearing loss, although the mechanism of the disease is poorly understood. It is well accepted that the endolymphatic sac is an immunocompetent organ and circulating autoantibodies against inner ear antigens have been reported, as have viral antigens in the endolymph, although the sensitivity, specificity, and roles of those antibodies in a disease process are poorly defined. We will describe the clinical aspects of the disease, the histopathology, the immunologic indicators, the types of presentation, both from the audiologic and vestibular point of view, clinical trials for treatment and the follow-up. One of our conclusions is that many of these patients respond favorably to the treatment Methotrexate.
KW - Autoimmune inner ear disease
KW - Methotrexate
KW - PET Scan
KW - Sensorineural hearing loss
UR - http://www.scopus.com/inward/record.url?scp=0642369624&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0642369624&partnerID=8YFLogxK
M3 - Article
C2 - 12940706
AN - SCOPUS:0642369624
SN - 1050-0545
VL - 14
SP - 225
EP - 230
JO - Journal of the American Academy of Audiology
JF - Journal of the American Academy of Audiology
IS - 4
ER -